Phosphorylation of ΔNp63α via a novel TGFβ/ALK5 signaling mechanism mediates the anti-clonogenic effects of TGFβ von Cherukuri, Pratima, DeCastro, Andrew J, Balboni, Amanda L, Downey, Sondra L, Liu, Jennifer Y, Hutchinson, Justine A, DiRenzo, James

Volltext

ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer stem cell activity and chemotaxis von DeCastro, Andrew J, Cherukuri, Pratima, Balboni, Amanda, DiRenzo, James

Volltext

Dietary intake of pterostilbene, a constituent of blueberries, inhibits the β-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats von Paul, Shiby, DeCastro, Andrew J, Lee, Hong Jin, Smolarek, Amanda K, So, Jae Young, Simi, Barbara, Wang, Chung Xiou, Zhou, Renping, Rimando, Agnes M, Suh, Nanjoo

Volltext

p53 and ΔNp63α Coregulate the Transcriptional and Cellular Response to TGFβ and BMP Signals von Balboni, Amanda L, Cherukuri, Pratima, Ung, Matthew, DeCastro, Andrew J, Cheng, Chao, DiRenzo, James

Volltext

ΔNp63α-Mediated Activation of Bone Morphogenetic Protein Signaling Governs Stem Cell Activity and Plasticity in Normal and Malignant Mammary Epithelial Cells von BALBONI, Amanda L, HUTCHINSON, Justine A, DIRENZO, James, DECASTRO, Andrew J, CHERUKURI, Pratima, LIBY, Karen, SPORN, Michael B, SCHWARTZ, Gary N, WELLS, Wendy A, SEMPERE, Lorenzo F, YU, Paul B

Volltext

p53 and ΔNp63α Co-regulate the Transcriptional and Cellular Response to TGFβ and BMP Signals von Balboni, Amanda L., Cherukuri, Pratima, Ung, Matthew, DeCastro, Andrew J., Cheng, Chao, DiRenzo, James

Volltext

miRNA function and modulation in stem cells and cancer stem cells von DeCastro, Andrew J., DiRenzo, James

Volltext

Phosphorylation of [DELTA]Np63[alpha] via a Novel TGF[beta]/ALK5 Signaling Mechanism Mediates the Anti-Clonogenic Effects of TGF[beta] von Cherukuri, Pratima, DeCastro, Andrew J, Balboni, Amanda L, Downey, Sondra L, Liu, Jennifer Y, Hutchinson, Justine A, DiRenzo, James

Volltext

Abstract 4549: CDK2 inhibition causes anaphase catastrophe through the centrosomal protein CP110 von Hu, Shanhu, Danilov, Alexey V., Godek, Kristina M., Orr, Bernardo, Tafe, Laura J., Memoli, Vincent A., Galimberti, Fabrizio, Ravi, Saranya, DeCastro, Andrew J., Lu, Yun, Mustachio, Lisa Maria, Sekula, David J., Andrew, Angeline S., Freemantle, Sarah J., Compton, Duane A., Dmitrovsky, Ethan

Volltext

Regulation of Mammary Stem Cell Quiescence via Post-Translational Modification of DeltaNp63alpha von DeCastro, Andrew J, Cherukuri, Pratima, DiRenzo, James

Volltext bestellen

Regulation of Mammary Stem Cell Quiescence via Post-Translational Modification of DeltaNp63alpha von DeCastro, Andrew J, Cherukuri, Pratima, DiRenzo, James

Volltext bestellen

Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study von Khan, Nicholas E., Bauer, Andrew J., Schultz, Kris Ann P., Doros, Leslie, Decastro, Rosamma M., Ling, Alexander, Lodish, Maya B., Harney, Laura A., Kase, Ron G., Carr, Ann G., Rossi, Christopher T., Field, Amanda, Harris, Anne K., Williams, Gretchen M., Dehner, Louis P., Messinger, Yoav H., Hill, D. Ashley, Stewart, Douglas R.

Volltext

Personalizing driver safety interfaces via driver cognitive factors inference von Sumner, Emily S., DeCastro, Jonathan, Costa, Jean, Gopinath, Deepak E., Kimani, Everlyne, Hakimi, Shabnam, Morgan, Allison, Best, Andrew, Nguyen, Hieu, Brooks, Daniel J., ul Haq, Bassam, Patrikalakis, Andrew, Yasuda, Hiroshi, Sieck, Kate, Balachandran, Avinash, Chen, Tiffany L., Rosman, Guy

Volltext

CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110 von Hu, Shanhu, Danilov, Alexey V, Godek, Kristina, Orr, Bernardo, Tafe, Laura J, Rodriguez-Canales, Jaime, Behrens, Carmen, Mino, Barbara, Moran, Cesar A, Memoli, Vincent A, Mustachio, Lisa Maria, Galimberti, Fabrizio, Ravi, Saranya, DeCastro, Andrew, Lu, Yun, Sekula, David, Andrew, Angeline S, Wistuba, Ignacio I, Freemantle, Sarah, Compton, Duane A, Dmitrovsky, Ethan

Volltext

Macrocephaly associated with the DICER1 syndrome von Khan, Nicholas E., Bauer, Andrew J., Doros, Leslie, Schultz, Kris Ann P., Decastro, Rosamma M., Harney, Laura A., Kase, Ron G., Carr, Ann G., Harris, Anne K., Williams, Gretchen M., Dehner, Louis P., Messinger, Yoav H., Stewart, Douglas R.

Volltext

Selinexor‐based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy von Chari, Ajai, Vogl, Dan T., Jagannath, Sundar, Jasielec, Jagoda, Unger, Thaddeus J., DeCastro, Andrew, Shah, Jatin, Kauffman, Michael, Shacham, Sharon, Jakubowiak, Andrzej

Volltext

Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients von Gasparetto, Cristina, Schiller, Gary J., Tuchman, Sascha A., Callander, Natalie S., Baljevic, Muhamed, Lentzsch, Suzanne, Rossi, Adriana C., Kotb, Rami, White, Darrell, Bahlis, Nizar J., Chen, Christine I., Sutherland, Heather J., Madan, Sumit, LeBlanc, Richard, Sebag, Michael, Venner, Christopher P., Bensinger, William I., Biran, Noa, Ammu, Sonia, Ben-Shahar, Osnat, DeCastro, Andrew, Van Domelen, Dane, Zhou, Tianjun, Zhang, Chris, Bentur, Ohad S., Shah, Jatin, Shacham, Sharon, Kauffman, Michael, Lipe, Brea

Volltext

Selinexor-Containing Regimens for the Treatment of Patients with Multiple Myeloma Refractory to Chimeric Antigen Receptor T-Cell (CAR-T) Therapy von Chari, Ajai, Vogl, Dan T., Jagannath, Sundar, Jasielec, Jagoda K., DeCastro, Andrew, Unger, TJ, Shah, Jatin, Jakubowiak, Andrzej

Volltext

Selinexor‐based regimens in patients with multiple myeloma after prior anti‐B‐cell maturation antigen treatment von Baljevic, Muhamed, Gasparetto, Cristina, Schiller, Gary J., Tuchman, Sascha A., Callander, Natalie S., Lentzsch, Suzanne, Monge, Jorge, Kotb, Rami, Bahlis, Nizar J., White, Darrell, Chen, Christine I., Sutherland, Heather J., Madan, Sumit, LeBlanc, Richard, Sebag, Michael, Venner, Christopher P., Bensinger, William I., Biran, Noa, DeCastro, Andrew, Van Domelen, Dane R., Zhang, Chris, Shah, Jatin J., Shacham, Sharon, Kauffman, Michael G., Bentur, Ohad S., Lipe, Brea

Volltext

Efficacy and Safety of Selinexor-Containing Regimens in Patients with Multiple Myeloma Previously Treated with Anti-CD38 Monoclonal Antibodies (αCD38 mAb) von Lentzsch, Suzanne, Lipe, Brea, Tuchman, Sascha A., Bahlis, Nizar J., Bensinger, William I., Sebag, Michael, Sutherland, Heather J., Monge, Jorge, Gasparetto, Cristina J., Baljevic, Muhamed, Callander, Natalie S., Venner, Christopher P., White, Darrell J., Kotb, Rami, Chen, Christine I., Schiller, Gary J., Madan, Sumit, Leblanc, Richard, DeCastro, Andrew, Bentur, Ohad S., Shah, Jatin J., Van Domelen, Dane R., Kauffman, Michael G., Shacham, Sharon, Biran, Noa

Volltext